Remove Arcturus Remove Funding Remove Startup
article thumbnail

Arcturus Gets $11M For 3D Video Editing Tools

socalTECH

Los Angeles-based Arcturus, a developer of 3D video editing tools, said Wednesday afternoon that it has raised $11M in a Series A funding round. The funding was led by Cloudtree Ventures, and also included Autodesk and Epic Games. The startup is led by CEO Kamal Mistry.

Arcturus 100
article thumbnail

RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug

Xconomy

San Diego-based Arcturus Therapeutics said today Cystic Fibrosis Foundation Therapeutics has agreed to provide $3 million to fund research and development of a new messenger RNA drug that could be broadly used to treat cystic fibrosis patients. Arcturus says its technology can be used to make.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Arcturus Board Sues Ex-CEO, Alleges Deceit, in Prelude to Proxy Fight

Xconomy

The board that fired Arcturus Therapeutics co-founder and CEO Joseph E. In a lawsuit filed Tuesday (see below) and in an open letter to shareholders issued Wednesday , the Arcturus (NASDAQ: ARCT ) board ­says a pattern of alleged misconduct, deceit, and failed leadership by Payne led to his termination on January 25. Payne, who.

article thumbnail

Sorrento Therapeutics Gets $2.3M

socalTECH

San Diego-based Sorrento Therapeutics , a new biotechnology startup, has raised $2.3M in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom.

Arcturus 100
article thumbnail

Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More

Xconomy

Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. billion, a figure compiled in the Venture Monitor Report.

Funding 52